This topic contains a solution. Click here to go to the answer

Author Question: Blood flow adaptations to anemia are achieved by increasing the respiration rate and ... (Read 97 times)

ashley

  • Hero Member
  • *****
  • Posts: 584
Blood flow adaptations to anemia are achieved by increasing the respiration rate and _________________
 
  a. Increasing the circulation rate.
  b. Decreasing 2,3-BPG
  c. Decreasing cardiac output
  d. Increasing blood viscosity

Question 2

CBC results on a pregnant patient indicate an MCV of 112 fl. What would be the most appropriate reflex test?
 
  a. Iron studies
  b. Bilirubin
  c. LDH
  d. Folate assay



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

hanadaa

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

Correct Answer: A

Answer to Question 2

Correct Answer: D




ashley

  • Member
  • Posts: 584
Reply 2 on: Jun 25, 2018
Thanks for the timely response, appreciate it


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library